Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ. (Q50217013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

title

Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

main subject

neoplastic stem cells

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

author name string

M Escoll

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

R Gargini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

A Cuadrado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

I M Anton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

language of work or name

English

0 references

publication date

6 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

1 April 2020

page(s)

3515-3527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

Contribution of p53 to metastasis

1 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Multiple Stress Signals Activate Mutant p53 In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Mutant p53 drives invasion by promoting integrin recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Influence of p53 mutations on prognosis of patients with glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Molecular definition of breast tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The biology of YAP/TAZ: hippo signaling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WASP-interacting protein (WIP): working in polymerisation and much more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP regulates persistence of cell migration and ruffle formation in both mesenchymal and amoeboid modes of motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

A role for WASP Interacting Protein, WIP, in fibroblast adhesion, spreading and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP: WASP-interacting proteins at invadopodia and podosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP is necessary for matrix invasion by breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

21 January 2018

p53 mutations in cancer

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Diacylglycerol kinase α controls RCP-dependent integrin trafficking to promote invasive migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Matrix crosslinking forces tumor progression by enhancing integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Genetic Defects in Severe Congenital Neutropenia: Emerging Insights into Life and Death of Human Neutrophil Granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP is critical for T cell responsiveness to IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP is a negative regulator of neuronal maturation and synaptic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The verprolin family of proteins: regulators of cell morphogenesis and endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Verprolin function in endocytosis and actin organization. Roles of the Las17p (yeast WASP)-binding domain and a novel C-terminal actin-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Stem cell regulation by the Hippo pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Dual role of YAP and TAZ in renewal of the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Metabolic control of YAP and TAZ by the mevalonate pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The Hippo pathway: regulators and regulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The Hippo-YAP pathway: new connections between regulation of organ size and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Role of YAP/TAZ in mechanotransduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

The Hippo pathway polarizes the actin cytoskeleton during collective migration of Drosophila border cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Modulating F-actin organization induces organ growth by affecting the Hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Hippo pathway regulation by cell morphology and stress fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Role of TAZ as mediator of Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Cancer stem cell-like phenotype and survival are coordinately regulated by Akt/FoxO/Bim pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2016.518

YAP1 increases organ size and expands undifferentiated progenitor cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28166194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Revisiting the role of p53 in primary and secondary glioblastomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28166194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2016.518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166194 AND SRC:MED&resulttype=core&format=json

release_jod3ge7lxbfohpggsuc72ln33u

1 April 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jod3ge7lxbfohpggsuc72ln33u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference